Competing interests
Psoriasis
BANG, PSORIASIS
WT has received research grants, consulting or speaker fees from AbbVie, Amgen, Celgene, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceuticals, Merck Sharp & Dohme, Novartis, Ono-Pharma, Pfizer, and UCB. AE has received research funding from AbbVie, Bristol Myers Squibb, the Danish National Psoriasis Foundation, Eli Lilly, Janssen Pharmaceuticals, the Kongelig Hofbuntmager Aage Bang Foundation, Novartis, Pfizer, and the Simon Spies Foundation, and honoraria as a consultant and/or speaker from AbbVie, Almirall, Bristol Myers Squibb, Dermavant, Eli Lilly, Galapagos NV, Galderma, Janssen Pharmaceuticals, LEO Pharma, Mylan, Novartis, Pfizer, Samsung Bioepis, Sun Pharmaceuticals, UCB, UNION Therapeutics, and Zuellig Pharma. ES has received honoraria/speaker fees from AbbVie, Eli Lilly, Janssen Pharmaceuticals, LEO Pharma, Novartis, MSD, Sanofi and UCB, and an independent research grant from Pfizer. PG is an employee of Janssen-Cilag Ltd, High Wycombe, UK. AT is an employee of Janssen-Cilag AB, Solna, Sweden. JB is an employee of Janssen Pharmaceutica NV, Beerse, Belgium. SW is an employee of Janssen-Cilag GmbH, Neuss, Germany. DM has received research grants and speaker fees from AbbVie, Bristol Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, and UCB.